About 70% of participants lost at least 5% of their initial body weight after taking the highest dose of Qsymia for 12 months
The gradual dose increase helps reduce the potential for gastrointestinal side effects, which are commonly observed with GLP-1 receptor agonists
Instead, the key is planned monitoring
Meal Plans and Supplement Bundles Eden has partnered with Gainful, among other providers, to give qualifying members custom protein, hydration, and gut health formulas
The retatrutide FDA timeline hinges on Phase 3 readouts
While oral formulations are gaining momentum, injectable therapies remain the preferred treatment option for many healthcare providers due to their established clinical evidence and long-term safety profiles